Table 3 Comparison of side effects in different patient groups
Characteristics | Â | Side effects | Â |
|---|---|---|---|
None or rough lesion texture | Oral pain or local ulcer | P value | |
Total, n (%) | 24 (48.0%) | 26 (52.0%) |  |
OLK history (month) | 6.2 ± 5.0 | 17.1 ± 9.3 | 0.017* |
Lesion classification | Â | Â | Â |
Non-homogenous | 4 (25.0%) | 12 (75.0%) | 0.009* |
Homogenous | 22 (64.7%) | 12 (35.3%) | Â |
Dysplastic pathology | Â | Â | Â |
Non-dysplastic | 9 (52.9%) | 8 (47.1) | 0.715 |
Mildly dysplastic | 10 (50.0%) | 10 (50.0%) | Â |
Moderately to severely dysplastic | 5 (38.5%) | 8 (61.5%) | Â |